MPS Pharmaa: Shareholders approve all resolutions at 32nd AGM

MPS Pharmaa Limited (formerly Advik Laboratories Limited) announced that all resolutions proposed at its 32nd Annual General Meeting (AGM) held on September 29, 2026, were duly passed by shareholders. Key approvals included the adoption of the Audited Financial Statements for the financial year ended March 31, 2026. Shareholders also re-appointed Mr. Ram Niwas Sharma as a Non-Executive Director and M/s. Nemani Garg Agarwal & Co. as Statutory Auditors for a further term of five years. Additionally, the appointment of Ms. Anchal Goyal as an Independent Director for five years was approved, along with Related Party Transactions and transactions under Section 185 of the Companies Act, 2013.